Dr Lars Abrahmsén appointed Chief Scientific Officer of AffibodyJanuary 27, 2004Affibody today announced the strengthening of the management team by the appointment of Dr Lars Abrahmsén as Chief Scientific Officer. Lars Abrahmsén succeeds Stefan St'åhl, one of Affibody's founders. Professor St'åhl wished to return to academia, and has returned to his academic professorship, but remains as scientific advisor to the Company. Dr Lars Abrahmsén is being recognized for his work on protein pharmaceuticals and in drug development. In addition, he conducted his postdoctoral work in the field of protein engineering. Most recently, Lars Abrahmsén was senior project team leader at Biovitrum. Commenting on his appointment, Lars Abrahmsén says: Torben J'¸rgensen, CEO of Affibody commented: | |||||||||||||||||||||
Science Research Departments
Earth Science Alternative Energy | Anthropology and Archaeology | Earthquakes and Volcanoes | Environment and Nature News | Global Warming | High-Energy and Particle Physics | Ozone Hole | Scientists Slow Light | Tsunami Space Science Astronomy and Space News | Black Holes | Chandra X-Ray Observatory | Extrasolar Planets | Hubble Telescope | International Space Station | Jupiter Galileo Mission | Jupiter Cassini Mission Flyby | Mars Exploration | Mars Odyssey 2001 | Mars Global Surveyor | Mars Polar Lander | Mars Climate Orbiter | Mars Pathfinder | Meteors and Asteroids | Mir Space Station | NEAR Asteroid Probe Mission | Pluto Planet Debate | Search for Extraterrestrial Life | Space Shuttle Program | Space Shuttle Mission: STS-102 | Space Weather Life Science Animal News | Biotechnology and Genetics | Brain Research | Human Cloning | Dinosaur and Fossil Discoveries | Endangered Species | Gene Therapy | Genetically Modified Food | Stem Cell Research | Whales and Whaling |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||